494 related articles for article (PubMed ID: 22946952)
1. Statistical considerations on design and analysis of bridging and multiregional clinical trials.
Tsong Y
J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952
[No Abstract] [Full Text] [Related]
2. Guest editors' note for the special issue on the statistical considerations for the design and analysis of bridging and multiregional clinical trials.
Tsong Y; Wang W
J Biopharm Stat; 2012 Sep; 22(5):875-8. PubMed ID: 22946936
[No Abstract] [Full Text] [Related]
3. Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
Chen CT; Hung HM; Hsiao CF
J Biopharm Stat; 2012 Sep; 22(5):1037-50. PubMed ID: 22946948
[TBL] [Abstract][Full Text] [Related]
4. Design and analysis issues of multiregional clinical trials with different regional primary endpoints.
Tsou HH; Tsong Y; Chang WJ; Dong X; Hsiao CF
J Biopharm Stat; 2012 Sep; 22(5):1051-9. PubMed ID: 22946949
[TBL] [Abstract][Full Text] [Related]
5. Qualitative consistency of treatment effects in multiregional clinical trials.
Tanaka Y; Li G; Wang Y; Chen J
J Biopharm Stat; 2012 Sep; 22(5):988-1000. PubMed ID: 22946945
[TBL] [Abstract][Full Text] [Related]
6. Sample size allocation to regions in a multiregional trial.
Uesaka H
J Biopharm Stat; 2009 Jul; 19(4):580-94. PubMed ID: 20183427
[TBL] [Abstract][Full Text] [Related]
7. Decision rules and associated sample size planning for regional approval utilizing multiregional clinical trials.
Chen X; Lu N; Nair R; Xu Y; Kang C; Huang Q; Li N; Chen H
J Biopharm Stat; 2012 Sep; 22(5):1001-18. PubMed ID: 22946946
[TBL] [Abstract][Full Text] [Related]
8. Assessment of regional treatment effect in a multiregional clinical trial.
Tsong Y; Chang WJ; Dong X; Tsou HH
J Biopharm Stat; 2012 Sep; 22(5):1019-36. PubMed ID: 22946947
[TBL] [Abstract][Full Text] [Related]
9. Multiregional clinical trials: Japanese perspective on drug development strategy and sample size for Japanese subjects.
Ando Y; Uyama Y
J Biopharm Stat; 2012 Sep; 22(5):977-87. PubMed ID: 22946944
[TBL] [Abstract][Full Text] [Related]
10. Design and sample size considerations for simultaneous global drug development program.
Huang Q; Chen G; Yuan Z; Lan KK
J Biopharm Stat; 2012 Sep; 22(5):1060-73. PubMed ID: 22946950
[TBL] [Abstract][Full Text] [Related]
11. A note on two approaches of testing bridging evidence to a new region.
Dong X; Guo Y; Tsong Y
J Biopharm Stat; 2012 Sep; 22(5):966-76. PubMed ID: 22946943
[TBL] [Abstract][Full Text] [Related]
12. Analysis of homogeneity of treatment effect in adaptive multicenter clinical trials.
Chen L; Tamura RN
J Biopharm Stat; 1998 Mar; 8(1):55-67. PubMed ID: 9547427
[TBL] [Abstract][Full Text] [Related]
13. Weighted evidence approach of bridging study.
Tsou HH; Tsong Y; Liu JT; Dong X; Wu Y
J Biopharm Stat; 2012 Sep; 22(5):952-65. PubMed ID: 22946942
[TBL] [Abstract][Full Text] [Related]
14. A predictive Bayesian approach to the design and analysis of bridging studies.
Gould AL; Jin T; Zhang LX; Wang WW
J Biopharm Stat; 2012 Sep; 22(5):916-34. PubMed ID: 22946940
[TBL] [Abstract][Full Text] [Related]
15. How to design a clinical trial.
Curtis BM; Barrett BJ; Parfrey PS
Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789
[No Abstract] [Full Text] [Related]
16. A Bayesian approach for inference from a bridging study with binary outcomes.
Gandhi M; Mukherjee B; Biswas D
J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
[TBL] [Abstract][Full Text] [Related]
17. Optimal allocation of sample sizes to multicenter clinical trials.
Lai D; Chang KC; Rahbar MH; Moye LA
J Biopharm Stat; 2013; 23(4):818-28. PubMed ID: 23786227
[TBL] [Abstract][Full Text] [Related]
18. Do multiinstitutional studies represent a higher level of research than single institution studies?
Naftel DC
J Heart Lung Transplant; 1996 Mar; 15(3):229-30. PubMed ID: 8777202
[No Abstract] [Full Text] [Related]
19. Test for the consistency of noninferiority from multiple clinical trials.
Yan X; Wang MC; Su X
J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
[TBL] [Abstract][Full Text] [Related]
20. [The use of state of the art statistical methodology in biomedical research: the example of methodology for interim analyses in clinical trials].
Muñoz SR; Bangdiwala SI
Rev Med Chil; 2001 Sep; 129(9):983-8. PubMed ID: 11725478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
